Democrats laud FDA move to lift estrogen therapy warning

The House Democratic Women’s Caucus praised the FDA and HHS Secretary Kennedy Jr. for removing the black-box warning on estrogen-based hormone replacement therapy, saying the change reflects science-based regulation. They urged continued research into safety and effectiveness, increased menopause research funding, better labeling and postmarket oversight, in a letter to Kennedy and FDA Commissioner Makary, with signatures from a broad group of Democratic lawmakers.